Experimental data indicate that restoring Wnt activation by adding Wnt ligands45 or inhibitors of Dickkoph-144 and glycogen synthase kinase-3β (GSK-3β)46 successfully attenuates Aβ toxicity and repairs cognition performance in animal model of AD. Here, GSK3B is linked to Alzheimer disease.